Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccrol Gp Regulatory News (ACRL)

Share Price Information for Accrol Gp (ACRL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 38.60
Bid: 38.60
Ask: 38.70
Change: 0.40 (1.05%)
Spread: 0.10 (0.259%)
Open: 38.30
High: 40.70
Low: 37.70
Prev. Close: 38.20
ACRL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Revised Banking Arrangements & Operational Update

1 May 2018 07:00

RNS Number : 6644M
Accrol Group Holdings PLC
01 May 2018
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

1 May 2018

Accrol Group Holdings plc

("Accrol", the "Company" or the "Group")

AIM: ACRL

 

REVISED BANKING ARRANGEMENTS, OPERATIONAL UPDATE AND CURRENT TRADING

 

Revised Banking Arrangements

 

Further to the information provided in the Trading Update announced on 19 March 2018 and following constructive discussions with its lender, Accrol announces that a number of matters regarding the Group's borrowing facilities have been agreed as outlined below:

 

· EBITDA covenants tests in respect of the periods ended 30 April 2018 and ending 31 July 2018 have been waived;

· the scheduled reduction in the limit of the Revolving Credit Facility which was due to occur on 30 April 2018 has been deferred until 31 October 2018; and

· indicative terms have been established for the lease funding of the new conversion line being installed at the Leyland plant in the next three months, which will allow the business to service major new business wins.

 

These revised banking arrangements, which are subject to the Company complying with certain undertakings to the lender during May 2018 (with which the Board expects to be able to comply) will help to support the growth of the business and enable the new management team to pursue the business recovery plan.

 

Operational Update

The Group is pleased to announce that it has recently entered heads of terms on the exit from the onerous central distribution hub in Skelmersdale. This planned exit is expected to have a positive impact on annualised profits, as previously reported, of at least £5 million.

Current Trading

 

The Company continues to trade in line with current market expectations.

 

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Gareth Jenkins, Chief Executive Officer

Tel: +44 (0) 1254 278 844

Martin Leitch, Interim Chief Finance Officer

Tel: +44 (0) 1254 278 844

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Andrew Jones

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

 Tel: +44 (0) 203 829 5000

 

 

Belvedere Communications Limited

 

Cat Valentine (cvalentine@belvederepr.com)

Tel: +44 (0) 7715 769 078

 

Notes to Editors

 

Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues as well as other tissue products to the UK's largest retailers. 

Accrol operates from three sites:

· A manufacturing, storage and distribution facility in Blackburn;

· A facial tissue plant, also in Blackburn; and

· A manufacturing, storage and distribution facility in Leyland.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGFDZGNGRZZ
Date   Source Headline
21st May 20202:25 pmRNSTR-1
6th May 20207:00 amRNSTrading Update
25th Mar 202010:19 amRNSTR-1
23rd Mar 202011:35 amRNSTR-1
17th Mar 20207:00 amRNSAppointment of Joint Broker
4th Mar 20207:00 amRNSTR-1
3rd Mar 20209:41 amRNSTR-1
29th Jan 20207:00 amRNSDirector's Dealing
21st Jan 20209:13 amRNSTR-1
20th Jan 20207:00 amRNSRegulatory investigation closed
15th Jan 20207:00 amRNSTR-1
14th Jan 20207:00 amRNSTR-1
7th Jan 20207:00 amRNSHalf Year Results
16th Dec 20197:00 amRNSTR-1
13th Nov 201912:11 pmRNSTR-1
22nd Oct 201911:30 amRNSResult of AGM
17th Oct 20198:00 amRNSVesting of FY2019 Share Option Awards
26th Sep 20198:30 amRNSNotice of AGM
6th Sep 201911:52 amRNSTR-1
3rd Sep 20197:00 amRNSAudited Final Results
10th Jun 20197:00 amRNSTrading Update and Notice of Results
25th Apr 20194:32 pmRNSDirector/PDMR Shareholding
10th Apr 20197:00 amRNSSenior Management Change
27th Mar 201910:20 amRNSRegulatory Investigation Update
11th Feb 20194:35 pmRNSDirector/PDMR Shareholding
6th Feb 20193:03 pmRNSHolding(s) in Company
22nd Jan 20195:15 pmRNSDirector's Dealing
22nd Jan 20199:05 amRNSSecond Price Monitoring Extn
22nd Jan 20199:00 amRNSPrice Monitoring Extension
22nd Jan 20197:01 amRNSHalf Year Results
22nd Jan 20197:00 amRNSBoard Change and Senior Management Appointment
21st Jan 20192:20 pmRNSRegulatory Investigation
10th Jan 20191:35 pmRNSHolding(s) in Company
8th Jan 201911:05 amRNSSecond Price Monitoring Extn
8th Jan 201911:00 amRNSPrice Monitoring Extension
8th Jan 20197:00 amRNSTrading Update
23rd Nov 20187:00 amRNSAccrol Group to present at Mello London
30th Oct 201811:37 amRNSResult of AGM
30th Oct 20187:00 amRNSPDMR Dealings
29th Oct 201811:24 amRNSBoard and Board Committee Changes
10th Oct 20187:00 amRNSAppointment of Non Executive Director
28th Sep 20187:00 amRNSAudited Final Results and Notice of AGM
26th Sep 20187:00 amRNSUnaudited Final Results 2018 and Banking Update
28th Aug 20187:00 amRNSBoard and Senior Management Changes
11th Jul 20187:00 amRNSNotice of Final Results
11th Jul 20187:00 amRNSDirectorate Change
9th Jul 20184:04 pmRNSHolding(s) in Company
18th Jun 20184:39 pmRNSDirector's Dealings
18th Jun 20187:00 amRNSHolding(s) in Company
12th Jun 20183:47 pmRNSDirectors' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.